Hiv Vaccine Trials Network

This study tested the safety and immune response of an experimental HIV vaccine in healthy infants born to mothers with HIV. The trial enrolled 38 mother-infant pairs, with infants receiving up to five vaccine doses starting in their first week of life. The main goals were to che…

This early-stage study tested the safety and immune response of a new experimental HIV vaccine in healthy adults. Thirty-four participants received either the vaccine or a placebo to see if it was well-tolerated and could trigger an immune defense against HIV. The goal was to gat…

This study tested whether people who got an experimental antibody (VRC01) before catching HIV could better control the virus without daily medication. 13 participants who started HIV treatment early stopped their pills under very close medical monitoring. Researchers watched to s…

This study aimed to understand how the body's immune system responds after recovering from a SARS-CoV-2 infection, which causes COVID-19. Researchers enrolled 760 adults who had previously tested positive for the virus and followed them for up to a year. By taking blood and nasal…